शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSESHREE PACETRONIX LTD.· Healthcare Equipment & SuppliesHighNeutral
Announced Thu, 13 Aug, 2026 · 16:54 IST

Shree Pacetronix Q1 FY27: revenue falls but profit grows YoY

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-8.6%Reaction day
₹142.50
prior close
₹138.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-8.7% vs market
Medical Equipment & Supplies peers, median of 11sector-0.1%-8.5% vs sector

On the reaction day the stock moved 8.7 pts less than Nifty Microcap 250 and 8.5 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
-1.4
15m
-1.4
30m
-1.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-8.6+0.1-8.7-0.1-8.5
Next day
-8.4+0.2-8.6-1.7-6.7
2d
-7.4+0.6-7.9-1.2-6.2
3d
-6.0-0.0-6.0+0.0-6.0
4d
-5.3+0.5-5.8-1.3-4.0
5d
-4.9+0.8-5.7-2.5-2.4
1w
-4.7+0.6-5.3+1.4-6.1
15d
-2.5+1.3-3.7-0.1-2.4
1m
+3.2-1.4+4.6-2.6+5.8
2m
+12.4-0.6+13.0-6.2+18.6
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shree Pacetronix reported Q1 FY27 standalone revenue of Rs 489.67 lakhs, down about 8% from Rs 534.30 lakhs YoY. PAT rose nearly 14% to Rs 76.31 lakhs from Rs 67 lakhs. Basic EPS at Rs 2.04 vs Rs 1.86. Total expenses fell to Rs 390.21 lakhs, helping margins. Consolidated PAT was Rs 75.59 lakhs. Auditor issued an unqualified limited review. Promoter shareholding rose.

Likely market impact

Mixed quarter with weaker topline but stronger earnings on cost cuts and margin expansion.